T cell proliferative responses against human papillomavirus type 16 E7 oncoprotein are most prominent in cervical intraepithelial neoplasia patients with a persistent viral infection

Journal of General Virology

Volumn 77, Issue 9, 1996, Pages 2183-2191

  De Gruijl, Tanja D ^a   Bontkes, Hetty J ^a   Stukart, Marij J ^a   Walboomers, Jan M M ^a   Remmink, Ans J ^a   Verheijen, René H M ^a   Helmerhorst, Theo J M ^a,b   Meijer, Chris J L M ^a   Scheper, Rik J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; VIRUS PROTEIN;

ADULT; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PERSISTENT INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROTYPING; T LYMPHOCYTE; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS INFECTION; WART VIRUS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES;

EID: 0029793131     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-77-9-2183     Document Type: Article

References (34)

1. Altmann, A., Jochmus-Kudielka, J., Frank, R., Gausepohl, H., Moebius, U., Gissmann, L. & Meuer, S. C. (1992). Definition of immunogenic determinants of the human papillomavirus type 16 nucleoprotein E7. European Journal of Cancer 28, 326-333.
2. Apple, R. J., Erlich, H. A., Klitz, W., Manos, M. M., Becker, T. M. & Wheeler, C. M. (1994). HLA-DR-DQ associations with cervical carcinoma show papillomavirus-type specificity. Nature Genetics 6, 157-162.
3. Bal, V., McIndoe, A., Denton, G., Hudson, D., Lombardi, G., Lamb, J. & Lechler, R. (1990). Antigen presentation by keratinocytes induces tolerance in human T cells. European Journal of Immunology 20, 1893-1697.
4. Biron, C. (1994). Cytokines in the generation of immune responses to and resolution of virus infection. Current Opinions in Immunology 6, 530-538.
5. Chen, L., Kinney Thomas, E., Hu, S.-L., Hellström, I. & Hellsröm, K. E. (1991). Human papillomavirus type 16 nucleoprotein E7 is a tumor rejection antigen. Proceedings of the National Academy of Sciences, USA 88, 110-114.
6. Clerici, M. & Shearer, G. M. (1993). A Th1/Th2 switch is a critical step in the etiology of HIV infection. Immunology Today 14, 107-111.
7. Comerford, S. A., McCance, D. J., Dougan, G. & Tite, J. P. (1991). Identification of T- and B-cell epitopes of the E7 protein of human papillomavirus type 16. Journal of Virology 65, 4681-4690.
8. Cromme, F. V., Meijer, C. J. L. M., Snijders, P. J. F., Uyterlinde, A., Kenemans, P., Helmerhorst, Th., Stern, P. L., van den Brule, A. J. C. & Walboomers, J. M. M. (1993). Analysis of MHC class I and II expression in relation to presence of HPV genotype in premalignant and malignant cervical lesions. British Journal of Cancer 68, 1372-1380.
9. Cubie, H. A. & Norval, M. (1988). Humoral and cellular immunity to papillomavirus in patients with cervical dysplasia. Journal of Medical Virology 24, 85-95.
10. Cubie, H. A., Norval, M., Crawford, L., Banks, L. & Crook, T. (1989). Lymphoproliferative response to fusion proteins of human papillomaviruses in patients with cervical intraepithelial neoplasia. Epidemiology and Infection 103, 625-632.
11. De Roda Husman, A. M., Walboomers, J. M. M., Meijer, C. J. L. M., Risse, E. K. J., Schipper, M. E. I., Helmerhorst, Th. J. M., Bleker, O. P., van den Brule, A. J. C. & Snijders, P. J. F. (1994). Analysis of cytomorphologically abnormal cervical scrapes for the presence of 27 mucosotropic human papillomavirus genotypes using polymerase chain reaction. International Journal of Cancer 56, 802-806.
12. Duggan-Keen, M., Keating, P. J., Cromme, F. V., Walboomers, J. M. M. & Stern, P. L. (1994). Alterations in major histocompatibility complex expression in cervical cancer: possible consequences for immunotherapy. Papillomavirus Report 5, 3-9.
13. Feltkamp, M. C. W., Smits, H. L., Vierboom, M. P. M., Minnaar, R. P., de Jongh, B. M., Drijfhout, J. W., ter Schegget, J., Melief, C. J. M. & Kast, M. W. (1993). Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells. European Journal of Immunology 23, 2242-2249.
14. Glew, S. S., Duggan-Keen, M., Cabrera, T. & Stern, P. L. (1992). HLA class II antigen expression in human papillomavirus-associated cervical cancer. Cancer Research 52, 4009-4016.
15. Goodman, R. E., Nestle, F., Yathi, M. N., Green, J. M., Thompson, C. B., Nickoloff, B. J. & Turka, L. A. (1994). Keratinocyte-derived T cell costimulation induces preferential production of IL-2 and IL-4 but not IFN-γ. Journal of Immunology 152, 5189-5198.
16. Halpert, R., Fruchter, R. G., Sedlis, A., Butt, K., Boyce, J. G. & Sillman, F. H. (1986). Human papillomavirus and lower genital neoplasia in renal transplant patients. Obstetrics and Gynecology 68, 251-258.
17. Kadish, A. S., Romney, S. L., Ledwidge, R., Tindle, R., Fernando, G. J. P., Zee, S. Y., van Ranst, M. A. & Burk, R. D. (1994). Cell-mediated immune responses to E7 peptides of human papillomavirus (HPV) type 16 are dependent on the HPV type infecting the cervix whereas serological reactivity is not type-specific. Journal of General Virology 75, 2277-2284.
18. Laga, M., Icenogle, J. P., Marsella, R., Manoka, A. T., Nzila, N., Ryder, R. W., Vermund, S. H., Heyward, W. L., Nelson, A. & Reeve, W. C. (1992). Genital papillomavirus infection and cervical dysplasia-opportunistic complications of HIV infection. International Journal of Cancer 48, 682-688.
19. McLean, C. S., Sterling, J. S., Mowat, J., Nash, A. A. & Stanley, M. A. (1993). Delayed-type hypersensitivity response to the human papillomavirus type 16 E7 protein in a mouse model. Journal of General Virology 74, 239-245.
20. + T-cell lines from HTLV-1 seronegative individuals: specificity and clonal heterogeneity. Blood 84, 1547-1554.
21. Muller, G., Saloga, J., Germann, T., Bellinghausen, I., Mohamadzadeh, M., Knop, J. & Enk, H. (1994). Identification and induction of human keratinocyte-derived IL-12. Journal of Clinical Investigations 94, 1799-1805.
22. Müller, M., Viscidi, R. P., Sun, Y., Guerrero, E., Hill, P. M., Shah, F., Bosch, F. X., Muñoz, N., Gissmann, L. & Shah, K. (1992). Antibodies to HPV-16 E6 and E7 proteins as markers for HPV-16 associated invasive cervical cancer. Virology 187, 508-514.
23. Remmink, A. I., Walboomers, J. M. M., Helmerhorst, Th. J. M., Voorhorst, F. J., Rozendaal, L., Risse, E. K. J., Meijer, C. J. L. M. & Kenemans, P. (1995). The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. International Journal of Cancer 61, 306-311.
24. Schäfer, A., Friedmann, W., Mielke, M., Schwartländer, B. & Koch, M. A. (1991). The increased frequency of cervical dysplasia-neoplasia in women infected with the human immunodeficiency virus is related to the degree of immunosuppression. American Journal of Obstetrics and Gynecology 164, 593-599.
25. Selvakumar, R., Borenstein, L. A., Lin, Y.-L., Ahmed, R. & Wettstein, F. O. (1994). T-cell response to cottontail rabbit papillomavirus structural proteins in infected rabbits. Journal of Virology 68, 4043-4048.
26. Shepherd, P. S., Tran, T. T. T., Rowe, A. J., Cridland, J. C., Comerford, S. A., Chapman, M. G. & Rayfield, L. S. (1992). T cell responses to the human papillomavirus type 16 E7 protein in mice of different haplotypes. Journal of General Virology 73, 1269-1274.
27. Smith, D. B. & Johnson, K. S. (1988). Single-step purification of polypeptide expressed in E. coli as fusions with glutathione-S-transferase. Gene 67, 31-40.
28. Steele, J. C., Stankovic, T. & Gallimore, P. H. (1993). Production and characterization of human proliferative T-cell clones specific for human papillomavirus type-1 E4 protein. Journal of Virology 67, 2799-2806.
29. Strang, G., Hickling, J. K., McIndoe, G. A. J., Howland, K., Wilkinson, D., Ikeda, H. & Rothbard, J. B. (1990). Human T cell responses to human papillomavirus type 16 L1 and E6 synthetic peptides: identification of T cell determinants, HLA-DR restriction, and virus type specificity. Journal of General Virology 71, 423-431.
30. Suchankova, A., Krcmar, M., Krchnak, V., Hamsikova, E., Kanka, J., Vagner, J. & Vonka, V. (1992). Range of HPV-16 E7 antibodies in cervical cancer patients and healthy subjects. International Journal of Cancer 51, 837-838.
31. Tindle, R. W., Fernando, G. J. P., Sterling, J. C. & Frazer, I. H. (1991). A "public" T-helper epitope of the E7 transforming protein of human papillomavirus 16 provides cognate help for several E7 B-cell epitopes from cervical cancer-associated human papillomavirus genotypes. Proceedings of the National Academy of Sciences, USA 88, 5887-5891.
32. Van den Brule, A. J. C., Meijer, C. J. L. M., Bakels, V., Kenemans, P. & Walboomers, J. M. M. (1990). Rapid detection of human papillomavirus in cervical scrapes by combined general primer-mediated and type-specific polymerase chain reaction. Journal of Clinical Microbiology 28, 2739-2743.
33. Viscidi, R. P., Sun, Y., Tsuzaki, B., Bosch, F. X., Muñoz, N. & Shah, K. V. (1993). Serologic response in human papillomavirus-associated invasive cervical cancer. International Journal of Cancer 55, 780-784.
34. zur Hausen, H. (1994). Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. In Human Pathogenic Papillomaviruses, pp. 131-156. Edited by H. zur Hausen. Berlin, Heidelberg & New York: Springer-Verlag.